ArticleFrontiers in immunology2025

Targeting PDPN enhances antitumor T-cell activity by disrupting β-catenin-mediated PD-L1 expression in melanoma.

Chunyan Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.